ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review

July 2021 | 42 pages | ID: S786DEB2FC0EN
GlobalData

Abstracts

ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development and active pharmaceutical ingredient manufacturing services to the pharmaceutical industry. The services include custom synthesis for early phase pharmaceutical activities, brand companies and APIs for the generic industry, among others. ScinoPharm also provides contract research and manufacturing services (CRAM) services including chemistry skill, analytical and regulatory services, chemical process development, clinical drug substances, exploratory process research and consulting services. The company has research and manufacturing facilities in Taiwan and China. ScinoPharm is headquartered in Tainan, Taiwan.

ScinoPharm Taiwan Ltd Key Recent Developments

Mar 02,2020: ScinoPharm’s transformation continues to yield results stable development in injection business

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

ScinoPharm Taiwan Ltd - Key Facts
ScinoPharm Taiwan Ltd - Key Employees
ScinoPharm Taiwan Ltd - Key Employee Biographies
ScinoPharm Taiwan Ltd - Major Products and Services
ScinoPharm Taiwan Ltd - History
ScinoPharm Taiwan Ltd - Company Statement
ScinoPharm Taiwan Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
ScinoPharm Taiwan Ltd - Business Description
Business Segment: Injection Products
Performance
Business Segment: Others
Performance
Business Segment: Products
Overview
Performance
Business Segment: Technical Services
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: India
Performance
Geographical Segment: Others
Performance
Geographical Segment: Taiwan
Performance
Geographical Segment: The USA
Performance
R&D Overview
ScinoPharm Taiwan Ltd - Corporate Strategy
ScinoPharm Taiwan Ltd - SWOT Analysis
SWOT Analysis - Overview
ScinoPharm Taiwan Ltd - Strengths
ScinoPharm Taiwan Ltd - Weaknesses
ScinoPharm Taiwan Ltd - Opportunities
ScinoPharm Taiwan Ltd - Threats
ScinoPharm Taiwan Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ScinoPharm Taiwan Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 02, 2020: ScinoPharm’s transformation continues to yield results stable development in injection business

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

ScinoPharm Taiwan Ltd, Key Facts
ScinoPharm Taiwan Ltd, Key Employees
ScinoPharm Taiwan Ltd, Key Employee Biographies
ScinoPharm Taiwan Ltd, Major Products and Services
ScinoPharm Taiwan Ltd, History
ScinoPharm Taiwan Ltd, Other Locations
ScinoPharm Taiwan Ltd, Subsidiaries
ScinoPharm Taiwan Ltd, Joint Venture
ScinoPharm Taiwan Ltd, Key Competitors
ScinoPharm Taiwan Ltd, Ratios based on current share price
ScinoPharm Taiwan Ltd, Annual Ratios
ScinoPharm Taiwan Ltd, Annual Ratios (Cont...1)
ScinoPharm Taiwan Ltd, Annual Ratios (Cont...2)
ScinoPharm Taiwan Ltd, Interim Ratios
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ScinoPharm Taiwan Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

ScinoPharm Taiwan Ltd, Performance Chart (2016 - 2020)
ScinoPharm Taiwan Ltd, Ratio Charts
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021